T0	Interventions 23 34	sitaxsentan
T1	Interventions 140 154	of sitaxsentan
T2	Interventions 225 247	BACKGROUND Sitaxsentan
T3	Interventions 411 429	Before sitaxsentan
T4	Interventions 526 556	receive placebo or sitaxsentan
T5	Interventions 845 860	for sitaxsentan
T6	Interventions 868 882	versus placebo
T7	Interventions 1019 1035	with sitaxsentan
T8	Interventions 1057 1071	strong placebo
T9	Interventions 1170 1211	receiving sitaxsentan 100Â mg than placebo
T10	Interventions 1316 1352	for 100-mg sitaxsentan patients than
T11	Interventions 1410 1437	frequently with sitaxsentan
T12	Interventions 1582 1604	CONCLUSION Sitaxsentan
T13	Interventions 1723 1740	patient receiving
T14	Interventions 1772 1791	clinical worsening;